1. Home
  2. FCNCA vs BNTX Comparison

FCNCA vs BNTX Comparison

Compare FCNCA & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FCNCA
  • BNTX
  • Stock Information
  • Founded
  • FCNCA 1898
  • BNTX 2008
  • Country
  • FCNCA United States
  • BNTX Germany
  • Employees
  • FCNCA N/A
  • BNTX N/A
  • Industry
  • FCNCA Major Banks
  • BNTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • FCNCA Finance
  • BNTX Health Care
  • Exchange
  • FCNCA Nasdaq
  • BNTX Nasdaq
  • Market Cap
  • FCNCA 24.9B
  • BNTX 26.4B
  • IPO Year
  • FCNCA N/A
  • BNTX 2019
  • Fundamental
  • Price
  • FCNCA $1,882.83
  • BNTX $98.15
  • Analyst Decision
  • FCNCA Buy
  • BNTX Strong Buy
  • Analyst Count
  • FCNCA 10
  • BNTX 18
  • Target Price
  • FCNCA $2,338.40
  • BNTX $139.49
  • AVG Volume (30 Days)
  • FCNCA 145.3K
  • BNTX 1.2M
  • Earning Date
  • FCNCA 10-23-2025
  • BNTX 11-03-2025
  • Dividend Yield
  • FCNCA 0.42%
  • BNTX N/A
  • EPS Growth
  • FCNCA N/A
  • BNTX N/A
  • EPS
  • FCNCA 169.70
  • BNTX N/A
  • Revenue
  • FCNCA $8,984,000,000.00
  • BNTX $3,380,387,551.00
  • Revenue This Year
  • FCNCA $0.68
  • BNTX N/A
  • Revenue Next Year
  • FCNCA $2.36
  • BNTX $13.50
  • P/E Ratio
  • FCNCA $11.06
  • BNTX N/A
  • Revenue Growth
  • FCNCA N/A
  • BNTX 6.98
  • 52 Week Low
  • FCNCA $1,473.62
  • BNTX $81.20
  • 52 Week High
  • FCNCA $2,412.93
  • BNTX $131.49
  • Technical
  • Relative Strength Index (RSI)
  • FCNCA 40.76
  • BNTX 40.46
  • Support Level
  • FCNCA $1,846.00
  • BNTX $90.12
  • Resistance Level
  • FCNCA $1,993.94
  • BNTX $100.84
  • Average True Range (ATR)
  • FCNCA 51.77
  • BNTX 3.99
  • MACD
  • FCNCA -9.62
  • BNTX -0.47
  • Stochastic Oscillator
  • FCNCA 16.03
  • BNTX 32.42

About FCNCA First Citizens BancShares Inc.

First Citizens BancShares Inc is the bank holding company of First Citizens Bank and Trust Company. The company's segments include the General Bank, the Commercial Bank, SVB Commercial, and Rail. The General Bank segment delivers products and services to consumers and businesses through its extensive network of branches and various digital channels. The Commercial Bank segment provides financial services, including lending, leasing, and advisory, to small and mid-market businesses across various industries. The SVB Commercial provides financial services to innovators, investors, and venture firms. The Rail segment provides tailored leasing and financing for railcars and locomotives across North America. It generates the majority of its revenue from the General Banking segment.

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.

Share on Social Networks: